Parallax Volatility Advisers, L.P. United Therapeutics Corp Transaction History

Parallax Volatility Advisers, L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$78.31 - $95.34 $442,451 - $538,671	-5,650 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$74.85 - $85.99 $393,411 - $451,963	5,256 Added 1334.01%	5,650 $450,000
Q2 2019 Aug 14, 2019	SELL	$76.06 - $120.81 $836 - $1,328	-11 Reduced 2.72%	394 $31,000
Q1 2019 May 15, 2019	SELL	$107.15 - $126.84 $1,500 - $1,775	-14 Reduced 3.34%	405 $48,000
Q4 2018 Feb 14, 2019	SELL	$101.4 - $128.73 $5,881 - $7,466	-58 Reduced 12.16%	419 $46,000
Q2 2018 Aug 14, 2018	BUY	$101.14 - $118.31 $202 - $236	2 Added 0.42%	477 $54,000
Q1 2018 May 15, 2018	BUY	$107.21 - $151.94 $17,582 - $24,918	164 Added 52.73%	475 $53,000
Q4 2017 Feb 14, 2018	BUY	$118.58 - $151.28 $31,186 - $39,786	263 Added 547.92%	311 $46,000
Q3 2017 Nov 14, 2017	BUY	$114.6 - $136.81 $5,500 - $6,566	48	48 $6,000

671

42.4M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $17.2B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.